Sleep, Oxytocin and Reward Processing in Women in the Postpartum Phase

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorInternational Research Training Group 2804

About this trial

During and after pregnancy, a woman's body and brain undergo significant changes that help her adapt to caregiving and emotional needs. However, this period also makes women more susceptible to emotional disorders, such as peripartum depression (PPD), which affects about 10-15% of new mothers. PPD can negatively impact both the mother and her baby, disrupting mood, motivation, and mothering abilities. Hormonal changes and poor sleep are some of the risk factors that might worsen these depressive symptoms.

Traditionally, sleep studies on PPD have relied on questionnaires and short-term sleep assessments. With the advent of smartwatches and digital devices, we can now monitor sleep in a home environment over longer periods. Oxytocin, a hormone crucial for childbirth, breastfeeding, and bonding with the baby, is thought to play a role in PPD. Studies suggest that higher levels of oxytocin might be linked to lower levels of postpartum depression, though findings are not always consistent. Oxytocin also affects sleep and is connected to brain areas that regulate reward and motivation.

This study aims to explore the relationship between sleep, oxytocin, and reward processing in new mothers. The investigators will include women with varying levels of depressive symptoms and use home-based sleep assessments to gather data. Our goal is to better understand how these factors interact in the postpartum period and how they might influence a mother's mental health and caregiving abilities.

The investigators expect that oxytocin levels are reduced in women with higher depressive symptoms and that these reductions are associated with sleep impairments, breastfeeding and altered reward processing.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Age: 18-40

Biological sex/gender: female

Swedish/English fluency

Postpartum phase: 6 weeks to 1 year

Disqualifiers

Age < 18

Neonatal complications

Trial population

Research participants will be recruited in the area of Uppsala, Sweden.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

objective sleep

Objective sleep measures assessed with tracking devices (Fitbit Inspire; Withings sleep analyser) e.g., total time spent in bed, wake time, wake frequency, sleep stages duration.

Time frame
7 consecutive nights
2

subjective sleep

Subjective sleep assessed by a daily sleep diary.

Time frame
7 consecutive days
3

oxytocin levels

Oxytocin levels assessed with saliva kits.

Time frame
7 consecutive days
4

breastfeeding

Assessment of breastfeeding behavior (onset, frequency and duration) with breastfeeding diaries.

Time frame
7 consecutive days

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

International Research Training Group 2804

Lead sponsor

Uppsala University

Collaborator

Uppsala University Hospital

Collaborator

This trial is not recruiting at the moment. You can still explore other options: